Estonia suspends the use of the Oxford–AstraZeneca vaccine by people under 60 years old following a report of a possible link with cases of blood clotting.
Estonia suspends the use of the Oxford–AstraZeneca vaccine to people over 60 years old following report of possible link with the blood clotting cases.
TheMinistryofHealthtemporarilyrestricts the use of the Oxford–AstraZeneca vaccine to people over 60 years old following areport of a"possible link" with veryrareblood clotting.
Estonia suspends the use of the Oxford–AstraZeneca vaccine in people under 60 years old following a report of a possible link with casesof blood clotting.
Belgiumtemporarilyrestricts the use of the Oxford–AstraZeneca vaccine to people over 55 years old following a report fromtheEuropeanMedicinesAgencythatthereisa"possible link"betweenthevaccineandveryrare blood clottingcases.
The MinistryofHealth restricts the use of the Oxford–AstraZeneca vaccine to people over 60 years old following a report of a "possible link" with very rare blood clotting.
Estonia suspends the use of the Oxford–AstraZeneca vaccine by people under 60 years old following a report of a possible link with casesof blood clotting.